- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
175 results for yuii
NCNA Stock: The Big Cancer Drug News Sending NuCana Skyrocketing
NuCana (NCNA) stock is surging higher on Wednesday after the company revealed fast track designation from the FDA for Acelarin.
SNGX Stock: The Big FDA News Giving Biotech Penny Stock Soligenix a Boost
Soligenix (SNGX) stock is roaring higher on Thursday thanks to some positive news from the U.S. Food and Drug Administration today.
NRBO Stock: 6 Things to Know About NeuroBo Pharma as Retail Investors Send Shares Rocketing
Neurobo Pharmaceuticals (NRBO) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company.
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher
Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).
MDGS Stock: 15 Things to Know About Medigus as the Penny Stock Soars
Medigus (MDGS) stock has caught the eye of investors on Friday with shares heading higher on news of pre-clinical trials doing well.
ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring
Aerpio Pharmaceuticals (ARPO) stock is flying high on Thursday after an analyst upgrade gave the company’s shares a boost today.
OCGN Stock: Why Red-Hot Ocugen Is on the Move Today
OCGN stock is on the move today after receiving orphan drug status for its OCU400 from the European Commission. Here’s what to know.
SENS Stock: Why Reddit Is Betting Big on a Short Squeeze for Senseonics Today
SENS stock is gaining ground as a potential short-squeeze play on r/WallStreetBets today. Here’s what you need to know about Senseonics.
Why Are Cannabis Stocks Down Today?
Cannabis stocks aren’t doing so hot on Wednesday as it appears banking legislation is unlikely to make it through Congress this year.
Why Is Harpoon Therapeutics (HARP) Stock Up 100%+ Today?
Harpoon Therapeutics (HARP) stock is taking off on Monday following the release of updated results from its myeloma drug candidate.
Why Is VolitionRX (VNRX) Stock Down 17% Today?
VolitionRX (VNRX) stock is taking a beating on Friday after the company revealed a proposed public offering for its shares.
Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?
Redhill Biopharma (RDHL) stock is rocketing higher on Friday after getting positive patent news from the USPTO for RHB-204.
Why Is Leafly (LFLY) Stock Getting High Today?
Leafly (LFLY) stock is in the news Monday after reaching an agreement with Uber’s (UBER) Uber Eats for the delivery of cannabis products.
Why Is Tricida (TCDA) Stock Down 90% Today?
Tricida (TCDA) stock is falling on Monday following the release of poor results from a Phase 3 chronic kidney disease clinical trial.
Why Is Hoth Therapeutics (HOTH) Stock Up 24% Today?
Hoth Therapeutics (HOTH) stock is rising higher on Monday with heavy trading and positive results from a Phase 1 clinical trial of BioLexa.
Why Is CASI Pharmaceuticals (CASI) Stock Up 700% Today?
CASI Pharmaceuticals (CASI) stock rocketed higher in pre-market trading this morning but it’s not due to any positive news from the company.
Why Is Axsome Therapeutics (AXSM) Stock Down Today?
Axsome Therapeutics (AXSM) stock is falling hard on Monday following a report about an upcoming decision from the FDA this week.
Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data.
Why Is BiomX (PHGE) Stock Down 11% Today?
BiomX (PHGE) stock is taking a beating on Wednesday after the clinical-stage microbiome company revealed details of a new private placement.
Why Is NexImmune (NEXI) Stock Down 4% Today?
NexImmune (NEXI) stock is falling on Friday as the immunotherapies company’s shares come off of a recent high earlier this week.
Why Is Fate Therapeutics (FATE) Stock Down 62% Today?
Fate Therapeutics (FATE) stock is falling on Friday after the company announced the termination of its collaboration with Janssen Biotech.
Why Is Ensyce Biosciences (ENSC) Stock Down 27% Today?
Ensyce Biosciences (ENSC) stock is taking a beating on Friday after the clinical-stage biotech company announced $8 million in financing.
KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today
Pasithea Therapeutics (KTTA) stock is heading higher on heavy trading Thursday even without any recent news from the biotech company.
5 – 8 of 175 results
